Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer

Recent work demonstrates that castration-resistant prostate cancer (CRPC) tumors harbor countless genomic aberrations that control many hallmarks of cancer. While some specific mutations in CRPC may be actionable, many others are not. We hypothesized that genomic aberrations in cancer may operate in...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Carly J., Woodward, Josha, Schwartzman, Jacob, Coleman, Daniel J., Lisac, Robert, Wang, Nicholas J., Van Hook, Kathryn, Gao, Lina, Urrutia, Joshua, Dane, Mark A., Heiser, Laura M., Alumkal, Joshi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762307/
https://www.ncbi.nlm.nih.gov/pubmed/29340039
http://dx.doi.org/10.18632/oncotarget.22560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762307/
https://www.ncbi.nlm.nih.gov/pubmed/29340039
http://dx.doi.org/10.18632/oncotarget.22560

Ejemplares similares